Atlas Trials

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT01642082 · COMPLETED

Trial details

NCT number
NCT01642082
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Squamous Cell CarcinomaEndometrial Transitional Cell CarcinomaEndometrial Undifferentiated CarcinomaRecurrent Uterine Corpus Carcinoma
Start date
2012-09-01
Primary completion
2016-01-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.